Brief: Hepion Pharmaceuticals Announces Termination Of Merger Agreement With Pharma Two B
11/12/2024 13:52
Dec 11 (Reuters) - Hepion Pharmaceuticals HEPA.O :
* HEPION PHARMACEUTICALS, INC. ANNOUNCES TERMINATION OF
MERGER
AGREEMENT WITH PHARMA TWO B LTD.
* HEPION PHARMACEUTICALS INC: NEITHER PARTY WILL BE REQUIRED
TO
PAY OTHER A TERMINATION FEE AS A RESULT OF MUTUAL DECISION TO
TERMINATE AGREEMENT
Source text: ID:nGNXsgxdY
Further company coverage: HEPA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hepion Pharmaceuticals
See all newsBrief: Hepion Pharmaceuticals Executes Binding Letter Of Intent With New Day Diagnostics To Commercialize Diagnostic Tests For Celiac Disease, Respiratory Multiplex, H. Pylori And Hcc
Brief: Hepion Pharma In-Licenses Diagnostic Tests from New Day Diagnostics- SEC Filing
Brief: Hepion Pharmaceuticals Announces Termination Of Merger Agreement With Pharma Two B
Brief: Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B
Brief: Pharma Two B Plans To Go Public Via Merger With Hepion Pharmaceuticals, Concurrent $11.5 Mln Private Placement